Insights and events
Mirjam Liebmann advises our national and international clients in the pharmaceutical, medical devices and biotech industry on all kinds of regulatory and commercial matters. The core area of her advice covers pharmaceutical and medical product law.
Mirjam focuses in particular on the set-up of the contractual relationship between different stakeholders in the health care sector, advice on compliance aspects when interacting with healthcare professionals and patient organisations, as well as advertising issues in relation to promoting pharmaceutical products (in the pre- and post-approval stage). She is particularly interested in working closely with her clients on complex issues and developing pragmatic and practical solutions. She has proven her business-oriented approach during a one-year secondment at an international pharma company where she has extensively advised on all kinds of interactions with patients, patient organisations and healthcare professionals, including the set-up of patient-support-programs, pre-approval communication and activities, and contractual engagements for speaker services, ad boards etc.
Already during her studies, as a research associate during her doctorate studies and during her legal traineeship, Mirjam focused on regulatory, advertising and contract law aspects of pharmaceutical and food law: She spent different stages at, inter alia, the competent authority for health and consumer protection in Hamburg as well as at a boutique-style law firm in Munich specialized on food and pharmaceutical law. Further, she worked at the German Embassy in Warsaw, Poland, as legal trainee.
Before Mirjam joined our highly recommended life sciences team, she has been working as a lawyer for another international law firm in Munich in the areas Life Sciences, IP, and Corporate and Commercial.
Advising an international pharma company on the set-up of a new patient-support program, and supporting the same company during the go-live phase of an already existing patient-support program.
Preparing compliance policies for national and international pharmaceutical companies.
Advising an international company on the contractual relationship with healthcare professionals and clinical institutions regarding the conduct of a market research.
Advising an international pharmaceutical company on regulatory aspects regarding the distribution of their products.
Advising various companies on the classification of medicinal apps as medical device.
Advising an international pharmaceutical company on the reimbursement of medicinal services for the benefit of patients and health insurance companies.
Advising a global pharmaceutical company on customer redress claims.
COVID 19 – Advising companies from various industry sectors on the manufacture and supply of masks, including advice on different regulatory requirements.
Advising an international pharmaceutical company on granting discounts on pharmaceutical products.
- Second State Exam in Law, Higher Regional Court of Hamburg, 2016
- Dr. iur., University of Hamburg, 2015
- First State Exam in Law, Bucerius Law School, 2011
- LL.B., Bucerius Law School, 2010
- Study Abroad, Dalhousie University Law School, Halifax, Nova Scotia, Canada, 2008